GENSCRIPT BIO(01548): Legend announces report published at the 2025 ASH Annual Meeting.
Kingsway Biotech (01548) issued an announcement that Legend Biotech Corporation ("Legend"), a joint venture company of the Company, whose shares are listed on the Nasdaq Global Select Market in the United States in the form of American Depositary Shares, announced on December 6, 2025 (New York time) that CARVYKTI (cilta-cel) had been presented in a verbal report at the 2025 American Society of Hematology ("ASH") Annual Meeting providing the long-term follow-up clinical and translational research data from the CARTITUDE-1 and CARTITUDE-4 studies in patients with relapsed or refractory multiple myeloma (RRMM).
GENSCRIPT BIO (01548) announced that Legend Biotech Corporation ("Legend"), a joint venture company of the Company, whose shares are listed on the NASDAQ Global Select Market in the form of American depositary shares, announced in a press release on December 6, 2025 (New York time) that at the 2025 American Society of Hematology ("ASH") Annual Meeting, it presented clinical and translational research data from the long-term follow-up studies of the CARTITUDE-1 and CARTITUDE-4 trials for CARVYKTI (cilta-cel) in patients with relapsed or refractory multiple myeloma (RRMM).
The latest results of the phase III CARTITUDE-4 study were also announced, as well as data showing the sustained remission rates in different subgroups and real-world research results of CARVYKTI through six poster presentations. Legend also presented the first-in-human trial data of the dual-target homologous allogeneic CAR-T candidate product LUCAR-G39D at the ASH Annual Meeting through an oral presentation.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
